Patent · US Active

Compounds, compositions and methods

US9815850B2 · kind B2 · utility

30Cited by
40References
41Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 3, 2017
Grant dateNov 14, 2017
Priority date—
Expiry dateFeb 3, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure relates generally to compounds and compositions, and their use as kinase inhibitors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.